Company Performance - Beauty Health Company (SKIN) reported a quarterly loss of 0.15pershare,whichwasworsethantheZacksConsensusEstimateofalossof0.12, and a decline from earnings of 0.05pershareayearago,representinganearningssurpriseof−2578.8 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 1.29%, but down from year-ago revenues of 97.4million[2]−Overthelastfourquarters,BeautyHealthhassurpassedconsensusEPSestimatestwotimesandtoppedconsensusrevenueestimatesthreetimes[2]StockPerformance−BeautyHealthshareshavelostapproximately43.40.06 on revenues of 90.45million,and−0.20 on revenues of $341.09 million for the current fiscal year [7] Industry Outlook - The Medical Services industry, to which Beauty Health belongs, is currently ranked in the bottom 45% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Beauty Health's stock performance [5]